Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2017-06-15 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-06-15 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated June 9, 2017, reporting the departure of a company officer (John E. Kuehner stepping down as Vice President, Operations). The key section is Item 5.02, which relates to changes in directors or certain officers. The document does not contain financial data or detailed reports but announces a management change. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (2159 characters), consistent with a management change announcement rather than a full report.
2017-06-15 English
IRANNOTICE
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission referencing a disclosure filed in a Form 10-Q quarterly report. It specifically states that the disclosure was made pursuant to certain legal provisions and that the Form 10-Q for the first quarter ended March 31, 2017, was filed on May 9, 2017. The document itself does not contain financial data or the report content but serves as a notice or certification regarding the filing of the Form 10-Q. The document length is short (1068 characters), and it is primarily an attestation by the General Counsel. According to the Certification Rule and the Menu vs Meal Rule, such a document should be classified as a Regulatory Filing (RNS) rather than the actual quarterly report (IR).
2017-05-09 English
10-Q
Interim / Quarterly Report Q1 2017
2017-05-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 9, 2017, reporting earnings for the first quarter ended March 31, 2017. It includes a press release as Exhibit 99.1 that reports financial results for the quarter. The document is relatively short (2708 characters) and primarily serves as an announcement of earnings results rather than a full detailed financial report. The text explicitly states it is a press release reporting earnings, which aligns with an Earnings Release. Therefore, the document is best classified as an Earnings Release (ER).
2017-05-09 English
FORM 4
Director's Dealing
2017-05-04 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.